Glycomimetics Inc. Stock
Glycomimetics Inc. Stock
Glycomimetics Inc. shows a slight decrease today, losing -€0.014 (-0.880%) compared to yesterday.
Our community is currently high on Glycomimetics Inc. with 5 Buy predictions and 0 Sell predictions.
With a target price of 7 € there is potential for a 310.32% increase which would mean more than doubling the current price of 1.71 € for Glycomimetics Inc..
So far the community has only identified positive things for Glycomimetics Inc. stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".
Pros and Cons of Glycomimetics Inc. in the next few years
Pros
?
B****
?
W********* I********* f** t** n*** y****
?
S********** s********
Cons
?
C******** o* t** e**********
?
M***** P*******
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Glycomimetics Inc. vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Glycomimetics Inc. | -0.880% | 11.649% | -33.229% | 38.250% | -24.513% | -14.271% | - |
Ardelyx Inc. | 28.120% | 34.723% | 18.969% | 89.624% | 39.758% | 44.250% | - |
Evolus Inc | 10.280% | 12.381% | -5.600% | 60.544% | 30.387% | 60.544% | - |
Salarius Pharmaceuticals Inc. | 11.650% | 7.981% | 17.949% | -67.606% | -17.117% | -98.248% | -99.993% |
Comments
GlycoMimetics, Inc. (NASDAQ: GLYC) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $8.00 price target on the stock.
Show more
Ratings data for GLYC provided by MarketBeat
GlycoMimetics, Inc. (NASDAQ: GLYC) had its "overweight" rating re-affirmed by analysts at Capital One Financial Co..
Show more
Ratings data for GLYC provided by MarketBeat
GlycoMimetics, Inc. (NASDAQ: GLYC) is now covered by analysts at Capital One Financial Co.. They set an "overweight" rating and a $12.00 price target on the stock.
Show more
Ratings data for GLYC provided by MarketBeat